Malaysia has seen a notable rise in COVID‑19 cases in recent months. In May 2025, increased mutation rates in the spike (S) protein of circulating variants raised concerns about the effectiveness of some rapid test kits. At Mediven, we remain steadfast in our commitment to public health and diagnostic excellence. The ProDetect® COVID-19 Antigen Rapid Test Kit is specifically designed to overcome these challenges, offering reliable detection across all major variants, including the recently emerged XFG strain (first identified in June 2025).
ProDetect® targets the nucleocapsid (N) protein of SARS-CoV-2, a more stable marker compared to the frequently mutating spike (S) protein. The test’s capture and detection antibodies are specifically chosen to avoid known mutation hotspots, ensuring reliable results even as the virus evolves.
| Variant | Lineage | Key Notes | Detection Status |
| XFG | Omicron lineage | High mutation load | Detected |
| KP.3 / KP.1.1 | Omicron sub-lineages | Widespread circulation in 2024–2025 | Detected |
| JN.1 | WHO variant of interest | Fast-spreading across multiple countries | Detected |
| EG.5 / EG.5.1 | Omicron sub-lineages | Previously dominant globally | Detected |
| XBB.1.5 | Recombinant Omicron | High transmissibility | Detected |
| BA.1 – BA.5 | Original Omicron variants | First major immune-evasive strains | Detected |
| Delta, Alpha | Historical major variants | High global impact during earlier waves | Detected |
*Detection confirmed through internal validation and alignment with known mutation profiles. Detailed mutation list available on request
Designed for point-of-care, clinics, mobile screening, and home use, ProDetect® continues to lead with speed, reliability, and variant-proof performance. As COVID-19 continues to mutate, you can trust ProDetect® to keep pace. Backed by ongoing surveillance and R&D, ProDetect® remains a critical frontline tool in early detection and pandemic management.
